Claus-Eric Ott

Claus-Eric Ott

Auto-generated profile, based on publicly available information

Claus-Eric Ott

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Institute for Medical and Human Genetics, Campus Virchow-Klinikum Berlin 13353

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SKSebastian Köhler
Sebastian Köhler
MSMarcel Schulz
Marcel Schulz
PKPeter Krawitz
Peter Krawitz
SBSebastian Bauer
Sebastian Bauer
SDSandra Dölken
Sandra Dölken
PRPeter N. Robinson
Peter N. Robinson

1 February 2007 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
EKEva Klopocki
Eva Klopocki
HSHarald Schulze
Harald Schulze
GSGabriele Strauß
Gabriele Strauß
COClaus-Eric Ott
Claus-Eric Ott
JHJudith Hall
Judith Hall
SMStefan Mundlos
Stefan Mundlos

4 September 2014 in Genome Biology
Verified
Journal Article
Open access
PDF file
JIJonas Ibn-Salem
Jonas Ibn-Salem
SKSebastian Köhler
Sebastian Köhler
MLMichael I Love
Michael I Love
HCHo-Ryun Chung
Ho-Ryun Chung
NHNi Huang
Ni Huang
PRPeter N. Robinson
Peter N. Robinson
Background: Recent data from genome-wide chromosome conformation capture analysis indicate that the human genome is divided into conserved megabase-sized self-interacting regions called topological domains. These topological domains form the regulatory backbone of the genome and are separated by regulatory boundary elements or barriers. Copy-number variations can potentially alter the topological domain architecture by deleting or duplicating the barriers and thereby allowing enhancers from neighboring domains to ectopically activate genes causing misexpression and disease, a mutational mechanism that has recently been termed enhancer adoption. Results: We use the Human Phenotype Ontology database to relate the phenotypes of 922 deletion cases recorded in the DECIPHER database to monogenic diseases associated with genes in or adjacent to the deletions. We identify combinations of tissue-specific enhancers and genes adjacent to the deletion and associated with phenotypes in the corresponding tissue, whereby the phenotype matched that observed in the deletion. We compare this computationally with a gene-dosage pathomechanism that attempts to explain the deletion phenotype based on haploinsufficiency of genes located within the deletions. Up to 11.8% of the deletions could be best explained by enhancer adoption or a combination of enhancer adoption and gene-dosage effects. Conclusions: Our results suggest that enhancer adoption caused by deletions of regulatory boundaries may contribute to a substantial minority of copy-number variation phenotypes and should thus be taken into account in their medical interpretation.

1 April 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
KDKatarina Dathe
Katarina Dathe
KKKlaus W. Kjaer
Klaus W. Kjaer
ABAnja Brehm
Anja Brehm
PMPeter Meinecke
Peter Meinecke
PNPeter Nürnberg
Peter Nürnberg
SMStefan Mundlos
Stefan Mundlos

1 March 2013 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
RBRaghu Bhushan
Raghu Bhushan
JGJohannes Grünhagen
Johannes Grünhagen
JBJessica Becker
Jessica Becker
PRPeter N. Robinson
Peter N. Robinson
COClaus-Eric Ott
Claus-Eric Ott
PKPetra Knaus
Petra Knaus

1 February 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AMAnne Michalk
Anne Michalk
SSSigmar Stricker
Sigmar Stricker
JBJutta Becker
Jutta Becker
RRRosemarie Rupps
Rosemarie Rupps
TPTapio Pantzar
Tapio Pantzar
KHKatrin Hoffmann
Katrin Hoffmann